(Q41679018)

7 October 2017

1 reference

title

Systemic antigen in the treatment of T-cell-mediated autoimmune diseases (English)

1 reference

7 October 2017

1

R. Liblau

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9425739

1 December 2024

author name string

R. Tisch

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9425739

1 December 2024

N. Bercovici

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9425739

1 December 2024

H. O. McDevitt

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9425739

1 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9425739

1 December 2024

publication date

1 December 1997

1 reference

7 October 2017

December 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9425739

full work available at URL

1 December 2024

https://api.elsevier.com/content/article/PII:S0167569997011717?httpAccept=text/xml

1 reference

10.1016/S0167-5699(97)01171-7

DOI

https://api.crossref.org/works/10.1016/S0167-5699(97)01171-7

https://api.elsevier.com/content/article/PII:S0167569997011717?httpAccept=text/plain

1 December 2024

1 reference

10.1016/S0167-5699(97)01171-7

DOI

https://api.crossref.org/works/10.1016/S0167-5699(97)01171-7

1 December 2024

1 reference

7 October 2017

volume

18

1 reference

7 October 2017

issue

12

1 reference

7 October 2017

page(s)

599-604

1 reference

Oral tolerance: immune mechanisms and treatment of autoimmune diseases

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Immunologic unresponsiveness induced by protein antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Specific Inhibition of Antibody Formation During Immunological Paralysis and Unresponsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

T cell priming versus T cell tolerance induced by synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Peripheral tolerance in T cell receptor-transgenic mice: evidence for T cell anergy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Peripheral selection of the T cell repertoire

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Clonal anergy blocks in vivo growth of mature T cells and can be reversed in the absence of antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Long life span of tolerant T cells and the role of antigen in maintenance of peripheral tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

T cell deletion follows chronic antigen specific T cell activation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

1 reference

7 January 2021

Induction of TH1 and TH2 immunity in neonatal mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Induction of apoptosis and T helper 2 (Th2) responses correlates with peptide affinity for the major histocompatibility complex in self-reactive T cell receptor transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

The injection of deaggregated gamma globulins in adult mice induces antigen-specific unresponsiveness of T helper type 1 but not type 2 lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

In vivo role of interleukin 4 in T cell tolerance induced by aqueous protein antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)-microglobulin-deficient BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Amelioration of Autoimmune Encephalomyelitis by Myelin Basic Protein Synthetic Peptide-Induced Anergy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Intravenous antigen administration as a therapy for autoimmune demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Inhibition of a novel model of murine experimental autoimmune orchitis by intravenous administration with a soluble testicular antigen: participation of CD8+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Identification of an immunosuppressive epitope of type II collagen that confers protection against collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Characterization of Resistance to Murine Experimental Autoimmune Thyroiditis: Duration and Afferent Action of Thyroglobulin- and TSH-Induced Suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Administration of myelin basic protein synthetic peptides to multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Insulin prophylaxis in individuals at high risk of type I diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Late complications of immune deviation therapy in a nonhuman primate

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Induction of Autoimmune Diabetes by Oral Administration of Autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Peptide antigen treatment of naive and virus-immune mice: antigen-specific tolerance versus immunopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901171-7

7 January 2021

10.1016/S0167-5699(97)01171-7

Identifiers

DOI

1 reference

7 October 2017

1 reference